GoHealth Inc. (NASDAQ:GOCO) price is hovering higher on Monday, September 13, jumping 1.30% above its previous close.
A look at today’s price movement shows that the recent level at last check reads $5.76, with intraday deals fluctuating between $5.38 and $5.80. Taking into account the 52-week price action we note that the stock hit a 52-week high of $16.37 and 52-week low of $4.00. The stock added 22.81% on its value in the past month.
GoHealth Inc., which has a market valuation of $1.76 billion, is expected to release its quarterly earnings report Nov 09, 2021 – Nov 15, 2021. Analysts tracking GOCO have forecast the quarterly EPS to shrink by -0.09 per share this quarter, while the same analysts predict the annual EPS to hit $0.45 for the year 2021 and up to $0.83 for 2022. In this case, analysts estimate an annual EPS growth of 304.50% for the year and 84.40% for the next year.
On average, analysts have forecast the company’s revenue for the quarter will hit $201.21 million, with the likely lows of $180.73 million and highs of $219.33 million. The average estimate suggests sales growth for the quarter will likely rise by 23.20% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of $1.26 billion for the company’s annual revenue in 2021. Per this projection, the revenue is forecast to grow 43.30% above that which the company brought in 2021.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give GOCO a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 10 analysts have assigned GOCO a recommendation rating as follows: 4 rate it as a Hold; 5 advise Buy while 1 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the GoHealth Inc. (GOCO) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Overweight, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that GOCO’s price is at present 17.27% off the SMA20 and -21.46% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 48.96, with weekly volatility standing at 8.62%. The indicator jumps to 8.96% when calculated based on the past 30 days. GoHealth Inc. (NASDAQ:GOCO)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 0.48. Considering analysts have assigned the stock a price target range of $7.00-$17.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $11.75. Based on this estimate, we see that today’s price at last check is roughly -19.86% off the estimated low and -191.1% off the forecast high. Investors will no doubt be excited to see the share price fall to $11.50, which is the median consensus price, and at that level GOCO would be -96.92% from recent price.
An analysis of the GoHealth Inc. (NASDAQ:GOCO) stock in terms of its daily trading volume indicates that the 3-month average is 3.20 million.
Current records show that the company has 320.81M in outstanding shares. The insiders’ percentage holdings are 0.60% of outstanding shares. But the -57.83% downside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.